Skip to main content

Table 2 Effect sizes of symptomatic outcomes

From: Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Outcomes

Interventions

No. of studies

Test of association

Test of heterogeneity

SMD

95% CI

P value

Model

I2 (%)

P value

Pain

G vs. PBO

14

− 0.105

(− 0.254, 0.045)

0.170

Random

72.50

0.000

C vs. PBO

12

− 0.216

(− 0.360, − 0.071)

0.003

Random

70.80

0.000

G + C vs. PBO

4

0.792

(− 0.296, 1.880)

0.153

Random

98.50

0.000

Overall

30

− 0.071

(− 0.228, 0.085)

0.369

Random

90.10

0.000

Function

G vs. PBO

11

− 0.126

(− 0.264, 0.012)

0.073

Random

64.10

0.002

C vs. PBO

10

− 0.220

(− 0.358, − 0.081)

0.002

Random

68.30

0.001

G + C vs. PBO

4

0.556

(− 0.368, 1.480)

0.238

Random

98.00

0.000

Overall

25

− 0.090

(− 0.242, 0.061)

0.242

Random

89.00

0.000

Stiffness

G vs. PBO

8

− 0.305

(− 0.609, − 0.002)

0.048

Random

89.00

0.000

C vs. PBO

3

0.026

(− 0.073, 0.126)

0.604

Fixed

31.70

0.232

G + C vs. PBO

2

− 0.070

(− 0.214, 0.074)

0.340

Fixed

0.00

0.582

Overall

13

− 0.142

(− 0.301, 0.017)

0.081

Random

82.90

0.000

  1. G glucosamine, C chondroitin, G + C glucosamine + chondroitin, PBO placebo